James B. Hermiller, MD, MSCAI Moderator		Allison G. Dupont, MD, FSCAI Moderator and Speaker
	Ryan D. Madder, MD, FSCAI Panelist and Speaker		Dawn Carol Scantlebury, MBBS, DM, FSCAI Panelist
	Daniel Higgins, R.T., (R)(CI)(ARRT) Panelist		Rajiv Mishra, PhD, CDPH, (RTCC) Panelist
	Islam Abudayyeh, MD, FSCAI Speaker		David Rizik, MD, MSCAI Speaker
	Andrew Michael Goldsweig, MD, FSCAI Speaker

• Welcome and Overview
• Scope of the Problem: Results of SCAI 2023 Occupational Health Hazards Survey
• The Cath Lab Is A Battlefield: Scope of Operator Injuries and Illness
• Advanced Imaging Technologies to Reduce Cath Lab Radiation: Protecting the Patients and Providers
• Discussion
• My Back is Killing Me! Can We Both Minimize Radiation Exposure and Leave our Lead Aprons on the Hook?
• Convincing Hospitals to Invest in Occupational Safety: What Works and How Can SCAI Assist?
• Panel Discussion

• Review the evidence demonstrating the substantial occupational hazards of the standard cardiac Cath Lab, including the risks of radiation exposure, the high frequency of orthopedic/spinal injury, and the deleterious impact on physician and staff wellness.
• Examine the advances in Cath Lab imaging systems that minimize radiation exposure to patients, physicians and staff by incorporating dose-reduction hardware and software technologies without compromising image quality.
• Discuss the breakthrough radiation shielding systems that allow for a lead-free environment (apron free) with minimal to no radiation exposure to staff and operators.
• Describe strategies to support and advocate for individual physicians and practices in gaining hospital administration financial support for these new technologies.

SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis. 

SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients. 

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. 

SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education.  
 
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.